Lubiprostone does not influence visceral pain thresholds in patients with irritable bowel syndrome (Q35251195)

7 August 2017

Lubiprostone does not influence visceral pain thresholds in patients with irritable bowel syndrome (English)

1 reference

7 August 2017

irritable bowel syndrome

1 reference

W E Whitehead

1

1 reference

7 August 2017

O S Palsson

2

1 reference

7 August 2017

L Gangarosa

3

1 reference

7 August 2017

M Turner

4

1 reference

7 August 2017

J Tucker

5

1 reference

7 August 2017

1 October 2011

1 reference

Neurogastroenterology and Motility

7 August 2017

1 reference

7 August 2017

23

1 reference

7 August 2017

10

1 reference

7 August 2017

944-e400

1 reference

Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial

7 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184461

Psychometric evaluation of patient-reported outcomes in irritable bowel syndrome randomized controlled trials: a Rome Foundation report

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184461

Lubiprostone: in constipation-predominant irritable bowel syndrome

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184461

Effect of a chloride channel activator, lubiprostone, on colonic sensory and motor functions in healthy subjects

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184461

Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome--results of two randomized, placebo-controlled studies.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184461

Contributions of pain sensitivity and colonic motility to IBS symptom severity and predominant bowel habits

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184461

Increased colonic pain sensitivity in irritable bowel syndrome is the result of an increased tendency to report pain rather than increased neurosensory sensitivity

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184461

Lubiprostone: chloride channel activator for chronic constipation

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184461

Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184461

SPI-0211 activates T84 cell chloride transport and recombinant human ClC-2 chloride currents

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184461

Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184461

Stool form scale as a useful guide to intestinal transit time

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184461

Pain from rectal distension in women with irritable bowel syndrome: relationship to sexual abuse.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3184461

Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation.

27 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01776.X

Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01776.X

Gastrointestinal and colonic segmental transit time evaluated by a single abdominal x-ray in healthy subjects and constipated patients

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21914041

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21914041

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Lubiprostone, a locally acting chloride channel activator, in adult patients with chronic constipation: a double-blind, placebo-controlled, dose-ranging study to evaluate efficacy and safety

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21914041

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2982.2011.01776.X

1 reference

7 August 2017

1 reference

7 August 2017

1 reference